$1.13 Billion is the total value of Bracebridge Capital, LLC's 69 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
New | ISHARES TRcall | $113,072,000 | – | 12,924 | +100.0% | 9.99% | – | |
New | KRANESHARES TRcall | $14,196,000 | – | 3,000 | +100.0% | 1.25% | – | |
New | KRANESHARES TRput | $14,196,000 | – | 3,000 | +100.0% | 1.25% | – | |
New | CLARUS THERAPEUTICS HLDNGS I | $10,673,000 | – | 2,002,495 | +100.0% | 0.94% | – | |
EACPU | New | EDIFY ACQUISITION CORPunit 11/25/2025 | $4,995,000 | – | 500,000 | +100.0% | 0.44% | – |
New | HEALTHWELL ACQUISITION CORPunit 08/05/2028 | $4,965,000 | – | 500,000 | +100.0% | 0.44% | – | |
KWEB | New | KRANESHARES TRcsi chi internet | $4,078,000 | – | 86,175 | +100.0% | 0.36% | – |
New | BLACK SPADE ACQUISITION COunit 99/99/9999 | $3,968,000 | – | 400,000 | +100.0% | 0.35% | – | |
New | BELONG ACQUISITION CORPunit 03/23/2026 | $2,985,000 | – | 300,000 | +100.0% | 0.26% | – | |
LCAP | New | LIONHEART ACQUISITION CORP I | $2,839,000 | – | 286,523 | +100.0% | 0.25% | – |
New | DIRECT SELLING ACQUISITIN COunit 99/99/9999 | $151,000 | – | 15,000 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
LIBERTY MEDIA CORP DEL | 16 | Q3 2023 | 10.0% |
AMBAC FINL GROUP INC | 16 | Q3 2023 | 6.2% |
AQUESTIVE THERAPEUTICS INC | 16 | Q3 2023 | 0.6% |
CLEAR CHANNEL OUTDOOR HLDGS | 16 | Q3 2023 | 0.6% |
DISH NETWORK CORPORATION | 11 | Q2 2022 | 5.5% |
ISHARES TR | 10 | Q3 2023 | 65.7% |
ISHARES TR | 10 | Q3 2023 | 72.3% |
COMPUTE HEALTH ACQUISITIN CO | 10 | Q2 2023 | 0.6% |
CHURCHILL CAPITAL CORP VII | 9 | Q1 2023 | 0.3% |
CHURCHILL CAPITAL CORP VI | 9 | Q1 2023 | 0.1% |
View Bracebridge Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Quotient Ltd | February 22, 2023 | 62,030 | 0.3% |
Clarus Therapeutics Holdings, Inc. | July 06, 2022 | 1,461,822 | 2.8% |
PERNIX THERAPEUTICS HOLDINGS, INC.Sold out | May 26, 2016 | 0 | 0.0% |
View Bracebridge Capital, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-10 |
13F-HR | 2024-02-12 |
SC 13G/A | 2024-02-08 |
SC 13D/A | 2023-11-17 |
4 | 2023-11-16 |
13F-HR | 2023-11-14 |
SC 13D/A | 2023-08-25 |
13F-HR | 2023-08-14 |
4 | 2023-08-04 |
SC 13D | 2023-06-16 |
View Bracebridge Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.